FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to a new ethinyl derivative of formula I in the form of a racemic mixture or respective enanthiomer and/or optic isomer and/or stereoisomer or to a pharmaceutically acceptable salt of the above compounds formed by acid addition. The compounds are allosteric modulators of metabotropic glutamate receptor subtype 5 (mGluR5) and can find application in treating diseases mediated by mGluR5 action, wherein a disease is schizophrenia, cognitive disorders, fragile X syndrome or autism. In formula I
,
U is N or C(R5); V is CH or N; W is CH or N; provided only one of the groups U, V or W is a nitrogen atom, R5 is hydrogen, methyl or halogen; Y is -N(R6)-, -O-, -C(R7')(R7)-, -CH2O- or -CH2S(O)2-; R6 is hydrogen or lower alkyl, whereas R7/R7' independently represent hydrogen, hydroxy group, lower alkyl or lower alkoxy group; R1 is phenyl or 5-6-merous heteroaryl containing 1-2 heteroatoms specified in nitrogen atoms, which can contain one or two substitutes specified in halogen or lower alkyl; R2/R2' independently represent hydrogen, lower alkyl, hydroxy group, lower alkoxy group, C3-C6-cycloalkyl, CH2-lower alkoxy group, or together with a carbon atom, to which they are attached, can form C3-C6-cycloalkyl, or a ring containing -CH2OCH2-; m is equal to 0, 1 or 2; if m is equal to 1, R3/R3' independently represent hydrogen, lower alkyl, CH2-lower alkoxy group, or together with a carbon atom, to which they are attached, can form C3-C6-cycloalkyl; or R3 and R2 together with a carbon atom, to which they are attached, can form C3-6-cycloalkyl or a ring containing -(CH2)2OCH2-; n is equal to 0 or 1; if n is equal to 1, R4/R4' independently represent hydrogen, lower alkyl, CH2-lower alkoxy group or together with a carbon atom, to which they are attached, can form C3-C6-cycloalkyl; R4 and R2 together with a carbon atom, to which they are attached, can form C3-6-cycloalkyl; or if n is equal to 0, and Y is -N(R6)-, then R6 and R2 together with a carbon atom and a nitrogen atom, to which they are attached, can form C3-6-cycloalkyl; if n and m are equal to 0, then R2 and R7 with a carbon atom, to which they are attached, can form C3-6-cycloalkyl.
EFFECT: producing the compounds mediated by mGluR5 action.
28 cl, 1 tbl, 174 ex
Title | Year | Author | Number |
---|---|---|---|
ETHINYL DERIVATIVES | 2010 |
|
RU2553461C2 |
POSITIVE ALLOSTERIC MODULATORS (PAM) | 2010 |
|
RU2561920C2 |
IMIDAZOLE DERIVATIVES AS mGluR5 ANTAGONISTS | 2010 |
|
RU2527106C2 |
OXAZOLINE DERIVATIVES FOR TREATING CNS DISORDERS | 2010 |
|
RU2569887C2 |
ETHYNYL DERIVATIVES AS MODULATORS OF METABOTROPIC GLUTAMATE RECEPTOR | 2016 |
|
RU2721776C2 |
INDOLIN-2-ONE AND 1,3-DIHYDRO-PYRROLO[3,2-C]PYRIDIN-2-ONE DERIVATIVES | 2015 |
|
RU2697512C2 |
DIHYDROOXAZOLE-2-AMINE DERIVATIVES | 2011 |
|
RU2587512C2 |
THIAZOLO[4,5-c]PYRIDINE DERIVATIVES mGluR5 RECEPTOR ANTAGONISTS | 2006 |
|
RU2425834C2 |
ETHYNYL DERIVATIVES | 2016 |
|
RU2722014C2 |
PYRIDINE-2-CARBOXAMIDE DERIVATIVES AS mGluR5 ANTAGONISTS | 2006 |
|
RU2411237C2 |
Authors
Dates
2016-01-20—Published
2011-04-11—Filed